The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of combined MRP1 inhibition and mutant p53-targeting compound APR-246.
 
Anna Sophia Ceder
Employment - Bayer (I)
Research Funding - Aprea Therapeutics
 
Sofi E. Eriksson
Research Funding - Aprea Therapeutics
 
Emarndeena Haji Cheteh
Research Funding - Aprea Therapeutics
 
Vladimir J.N. Bykov
Stock and Other Ownership Interests - Aprea Therapeutics
Research Funding - Aprea Therapeutics
Patents, Royalties, Other Intellectual Property - Aprea Therapeutics
 
Lars Abrahmsen
Employment - Aprea Therapeutics
Leadership - Aprea Therapeutics
 
Klas G. Wiman
Stock and Other Ownership Interests - Aprea Therapeutics
Consulting or Advisory Role - Aprea Therapeutics
Research Funding - Aprea Therapeutics
Patents, Royalties, Other Intellectual Property - Aprea Therapeutics
Travel, Accommodations, Expenses - Aprea Therapeutics
Other Relationship - Aprea Therapeutics